Thionucleotides as inhibitors of ribonucleotide reductase. 2003

B Roy, and S Chambert, and M Lepoivre, and J L Décout
Institut de Biochimie Biophysique Moléculaire et Cellulaire, Université de Paris Sud, UMR CNRS 8619, Orsay, France.

Ribonucleosides and xylonucleosides bearing a disulfide function on the sugar ring were synthesized. Ribonucleosides belonging to the cytidine series were found to efficiently reduce dNTP pools in the human lymphoblastoid CEM/SS cell line.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D003562 Cytidine A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. Cytosine Ribonucleoside,Cytosine Riboside,Ribonucleoside, Cytosine,Riboside, Cytosine
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D012264 Ribonucleotide Reductases Ribonucleotide Reductase,Reductase, Ribonucleotide,Reductases, Ribonucleotide
D013873 Thionucleotides Nucleotides in which the base moiety is substituted with one or more sulfur atoms.
D014994 Xylose D-Xylose,D Xylose

Related Publications

B Roy, and S Chambert, and M Lepoivre, and J L Décout
January 2012, Current topics in medicinal chemistry,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
September 2006, Antiviral research,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
January 1987, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
August 1989, Journal of medicinal chemistry,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
January 2005, Advances in enzyme regulation,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
January 1986, Leprosy review,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
March 1975, Molecular pharmacology,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
August 2006, Current cancer drug targets,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
March 1979, Cancer research,
B Roy, and S Chambert, and M Lepoivre, and J L Décout
December 1970, Biochemical and biophysical research communications,
Copied contents to your clipboard!